These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Synthesis and beta-lactamase inhibitory properties of 2 beta-[(1,2,3-triazol-1-yl)methyl]-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide and related triazolyl derivatives. Micetich RG; Maiti SN; Spevak P; Hall TW; Yamabe S; Ishida N; Tanaka M; Yamazaki T; Nakai A; Ogawa K J Med Chem; 1987 Aug; 30(8):1469-74. PubMed ID: 3039137 [TBL] [Abstract][Full Text] [Related]
7. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors. Qadri SM; Ueno Y; Cunha BA Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972 [TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin . Livermore DM; Seetulsingh P J Antimicrob Chemother; 1991 Jun; 27(6):761-7. PubMed ID: 1669013 [TBL] [Abstract][Full Text] [Related]
9. An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase. Cherubin CE; Eng RH; Smith SM; Tan EN J Antimicrob Chemother; 1991 Jul; 28(1):61-70. PubMed ID: 1769944 [TBL] [Abstract][Full Text] [Related]
10. Comparative activities of novel beta-lactamase inhibitors, 6-exomethylene penamsulfones (CH1240, CH2140) in experimental mouse infection model. Park KW; Yim CB; Kim KH Arch Pharm Res; 1998 Oct; 21(5):527-30. PubMed ID: 9875489 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and beta-lactamase inhibitory activities of some clavulanic acid analogues. Mak CP; Prasad K; Turnowsky F J Antibiot (Tokyo); 1983 Apr; 36(4):398-406. PubMed ID: 6602120 [TBL] [Abstract][Full Text] [Related]
12. Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors. Thomson CJ; Amyes SG J Antimicrob Chemother; 1993 May; 31(5):655-64. PubMed ID: 8392995 [TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of the plasmid-encoded TEM-1 beta-lactamase in Scotland. Thomson CJ; Amyes SG Epidemiol Infect; 1993 Feb; 110(1):117-25. PubMed ID: 8432315 [TBL] [Abstract][Full Text] [Related]
19. In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates. Zhang D; Wang Y; Lu J; Pang Y Antimicrob Agents Chemother; 2016 Jan; 60(1):393-9. PubMed ID: 26525785 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and beta-lactamase inhibitory activity of 6-[(1-heteroarylthioethyl-1,2,3-triazol-4-yl)-methylene]penam sulfones. Im C; Maiti SN; Micetich RG; Daneshtalab M; Atchison K; Phillips OA; Kunugita C J Antibiot (Tokyo); 1994 Sep; 47(9):1030-40. PubMed ID: 7928691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]